Filing Details
- Accession Number:
- 0001485003-16-000122
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-29 16:16:32
- Reporting Period:
- 2016-06-27
- Filing Date:
- 2016-06-29
- Accepted Time:
- 2016-06-29 16:16:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1485003 | Eleven Biotherapeutics Inc. | EBIO | Pharmaceutical Preparations (2834) | 252025616 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1589888 | L Karen Tubridy | C/O Eleven Biotherapeutics, Inc., 215 First Street, Suite 400 Cambridge MA 02142 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-06-27 | 4,372 | $2.08 | 32,753 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.
- Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $2.00 to $2.11 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
